Inactivation of deubiquitinase CYLD enhances therapeutic antibody production in Chinese hamster ovary cells

Applied Microbiology and Biotechnology
Yafang LuBuchang Zhang

Abstract

Chinese hamster ovary (CHO) cells are promising host engineering cells for industry manufacturing of therapeutic antibodies. However, cell death due to apoptosis remains a huge challenge to augment antibody production, and developing CHO cells with enhanced anti-apoptosis and proliferation ability is fundamental for cell line development and high-yielding bioprocesses. Deubiquitinase cylindromatosis (CYLD) has been proved to be a tumor suppressor by negatively regulating NF-κB and Wnt/β-catenin signaling pathways. Its mutation or deletion is a common chromosome variation in several types of cancers. Here, we engineered CHO CYLD-/- cells by CRISPR-Cas9 editing technology. These cells displayed stronger cell proliferation and anti-apoptosis ability compared to parental cells. Three antibody expression plasmid kits were transiently transfected into these cells. Our data showed that inactivation of CYLD increased the highest titers of rituximab, Herceptin, and one bispecific antibody by 105, 63, and 228%, respectively. Reversely, overexpression of CYLD could promote cell apoptosis, whereas inhibiting cell proliferation and antibody production. Furthermore, inhibition of CYLD in CHO cells stably expressing an IgG antibody (CHO-IgG) ...Continue Reading

References

Oct 6, 1998·Annual Review of Biochemistry·A Hershko, A Ciechanover
Jun 3, 2000·Nature Genetics·G R BignellS Rasmussen
Mar 3, 2004·Biotechnology and Bioengineering·Jing-Xiu BiMohamed Al-Rubeai
May 5, 2005·Molecular and Cellular Biology·William ReileyShao-Cong Sun
Jun 16, 2006·Carcinogenesis·Claus HellerbrandAnja K Bosserhoff
Jul 25, 2006·Metabolic Engineering·Sing Fee LimZhiwei Song
Jun 5, 2007·Journal of Biotechnology·Kelly AstleyMohamed Al-Rubeai
Jul 19, 2008·EMBO Reports·Constantin S FriedmanAdrian T Ting
May 26, 2009·Biotechnology Advances·David L HackerFlorian M Wurm
Aug 12, 2009·Analytical Chemistry·Tyler CarlageWilliam S Hancock
Sep 9, 2009·BMC Biotechnology·Darrin Kuystermans, Mohamed Al-Rubeai
Jun 22, 2011·Proceedings of the National Academy of Sciences of the United States of America·Wolfgang SchaeferChristian Klein
Aug 2, 2011·Nature Biotechnology·Xun XuJun Wang
Dec 23, 2011·Biotechnology and Bioengineering·Stephanie HammondKelvin H Lee
Jan 5, 2013·Science·Le CongFeng Zhang
Oct 23, 2013·Metabolic Engineering·Michaela StrotbekMonilola A Olayioye
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Jan 9, 2014·Breast Cancer Research and Treatment·Mitsuhiro HayashiYukio Ando
Jan 11, 2014·Nature Biotechnology·Rob Saurabh Aggarwal
Mar 13, 2014·Biotechnology and Bioengineering·Adam J BrownDavid C James
Sep 16, 2014·Biotechnology and Bioengineering·Yuzhou FanMikael Rørdam Andersen
Dec 21, 2014·Biotechnology Letters·Paul S KellyNiall Barron
Apr 4, 2015·Science·Padmanee Sharma, James P Allison
May 24, 2015·Molecular and Cellular Biochemistry·Xiaoli YangZirui Zheng
Nov 8, 2015·Microbial Pathogenesis·Changzhi XuDavid Weaver

❮ Previous
Next ❯

Datasets Mentioned

BETA
DB00073
DB00072
US8486895

Methods Mentioned

BETA
PCR
enzyme-linked immunosorbent assay
ELISA
transfection
size exclusion chromatography
flow cytometry

Software Mentioned

Image J
hErbitux

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.